30 November 2010
Ghrelin inhibits apoptosis induced by palmitate in rat aortic endothelial cells
Dan ZhangABCDEFG, Wei WangABDE, Yijun ZhouDEF, Ying ChenBDE, Lingling HanBC, Ying LiuAF, Cupping CaoBC, Hong ZhaoAF, Guoliang LiuACDEFGMed Sci Monit 2010; 16(12): BR396-403 :: ID: 881291
Abstract
Background: Ghrelin is the endogenous ligand of the growth hormone secretagogue receptor. It has been reported to have cardiovascular protective activities. Elevated plasma free fatty acids trigger apoptosis in vascular endothelial cells. We investigated the effect of ghrelin on palmitate-induced apoptosis in rat aortic endothelial cells and the involved transduction pathway.
Material/Methods: Rat aortic endothelial cells were treated with palmitate in the presence or absence of ghrelin. Apoptosis was detected using an annexin V-FITC/PI binding assay and a caspase-3 activity assay. The intracellular reactive oxygen species formation in endothelial cells was detected by fluorescence measurement with dichlorofluorescein diacetate (DCFH-DA). Western blot analysis was used to examine the changes in the expression levels of Akt, Bcl-2, and Bax.
Results: Exposure of rat aortic endothelial cells to palmitate (0.3 mM) for 24 hours caused a significant increase in cell apoptosis. Ghrelin attenuated palmitate-induced apoptosis in endothelial cells. Exposure of cells to ghrelin caused a rapid activation of Akt. These effects were abolished by [D-Lys3]-GHRH-6, the special antagonist of growth hormone secretagogue receptor. Phosphatidyl inositol 3-kinase (PI3K) inhibitor, LY294002, extenuated the antiapoptotic effect of ghrelin. Reactive oxygen species levels were increased by palmitate, but this effect was inhibited by ghrelin. In addition, ghrelin increased the expression of Bcl-2 and decreased the expression of Bax; thus, the Bcl-2/Bax ratio was increased.
Conclusions: Ghrelin inhibits palmitate-induced apoptosis involved in activating the PI3K/Akt pathway and suppressing palmitate-induced oxidative stress in endothelial cells. Ghrelin may be protective against palmitate-induced endothelial injury.
Keywords: Oligopeptides, Palmitates - toxicity, Morpholines, Ghrelin - pharmacology, Fluorescence, Endothelial Cells - drug effects, Chromones, Cell Survival - drug effects, Blotting, Western, Aorta - cytology, Analysis of Variance, Reactive Oxygen Species - metabolism, Signal Transduction - drug effects, Tetrazolium Salts, Thiazoles
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Evaluating Pelvic Floor Dysfunction in Female Horse Show Jumpers Using the Australian Pelvic Floor Question...Med Sci Monit In Press; DOI: 10.12659/MSM.946830
Clinical Research
Predictive Value of Platelet Aggregation Tests in Recurrent Cerebral Ischemia and Major BleedingMed Sci Monit In Press; DOI: 10.12659/MSM.947172
Clinical Research
Impact of Nurse-Led Versus Surgeon-Led Preoperative Counseling and Follow-Up on Postoperative Outcomes in P...Med Sci Monit In Press; DOI: 10.12659/MSM.945597
Clinical Research
Evaluation of Attitudes to Learning Doctor-Patient Communication Skills in 427 Postgraduate Doctors Using t...Med Sci Monit In Press; DOI: 10.12659/MSM.947276
Most Viewed Current Articles
17 Jan 2024 : Review article 6,973,921
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,258
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,430
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 21,545
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912